GaryAnthonyAbramsMD
Gastroenterology • Greenville, SCHepatology & Liver Transplantation
Chief, Gastroenterology and Liver Center
Dr. Abrams is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
706 grove st
Greenville, SC 29605Phone+1 864-238-1197
Education & Training
Yale-New Haven Medical CenterFellowship, Gastroenterology, 1992 - 1995- Yale-New Haven Medical CenterResidency, Internal Medicine, 1990 - 1992
Albert Einstein College of MedicineClass of 1990
Certifications & Licensure
SC State Medical License 2014 - 2025
AL State Medical License 1995 - 2013
CT State Medical License 1992 - 1995- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- AOA Albert Einstein College of Medicine, 1989-1990
Clinical Trials
- Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment Start of enrollment: 2015 Sep 22
- Efficacy, Safety and Tolerability of the Combination of Tropifexor & Licogliflozin and Each Monotherapy, Compared With Placebo in Adult Patients With NASH and Liver Fibrosis. Start of enrollment: 2019 Dec 30
- A Study to Assess the Efficacy and Safety of VK2809 for 52 Weeks in Subjects With Biopsy Proven NASH Start of enrollment: 2019 Nov 15
Publications & Presentations
PubMed
- 223 citationsA Randomized, Double-Blinded, Placebo-Controlled Multicenter Trial of Etanercept in the Treatment of Alcoholic HepatitisNicholas C. Boetticher, Craig J. Peine, Paul Y. Kwo, Gary A. Abrams, Tushar Patel
Gastroenterology. 2008-12-01 - 3 citationsA corny cause of cerebrospinal fluid ascites: A case report and review of literature:Hira Jamal, Gary A. Abrams
SAGE Open Medical Case Reports. 2016-01-01 - 25 citationsSafety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled,...Stephen A Harrison, Juan P Frias, Guy Neff, Gary A Abrams, K Jean Lucas
The Lancet. Gastroenterology & Hepatology. 2023-12-01
Professional Memberships
- Member
- Member
- American Association for the Study of Liver DiseaseMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
